GlassScriptPhysician profile
Christina Braun
NPI 1366419913
$3,956.93
in general payments reported to CMS, 2019-2025
18 companies · $657 in 2025
The $657 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $211 · 2022: $536 · 2023: $1,136 · 2024: $893 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,686.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,358.96 | 2022-2025 | Xen Glaucoma Treatment System, Lumigan, Vuity |
| Alcon Vision LLC | $573.96 | 2020-2025 | Clareon, Acrysof Iq Panoptix Uv Iol, Acrysof Iq Vivity |
| Allergan, INC. | $473.21 | 2019-2022 | |
| Sight Sciences, INC. | $225.68 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Tarsus Pharmaceuticals, INC. | $188.04 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $161.26 | 2025 | Vevye |
| Rxsight INC | $151.13 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $145.08 | 2019 | |
| Coopervision INC. | $143.27 | 2024 | Misight Contact Lens |
| Dompe US, INC. | $124.74 | 2023 | Oxervate |
| Apellis Pharmaceuticals, INC. | $112.50 | 2023 | Syfovre |
| Astellas Pharma US INC | $100.00 | 2024 | Izervay |
| Bausch & Lomb Americas INC. | $79.91 | 2023-2024 | Miebo, Xiidra |
| Carl Zeiss Meditec, INC. | $60.00 | 2022 | |
| Aerie Pharmaceuticals, INC. | $16.80 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oasis Medical, INC. | $15.00 | 2019 | |
| Kala Pharmaceuticals, INC. | $14.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Braun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.